FDAnews
www.fdanews.com/articles/157239-nine-indian-drug-firms-may-have-to-pay-419-million

Nine Indian Drug Firms May Have to Pay $419 Million

July 19, 2013
Nine Indian pharma firms including Ranbaxy and Dr. Reddy’s may have to pay fines of approximately $419 million for selling the asthma drug Doxofylline without first getting the drug’s price approved.
Business Standard